---
title: "Acrivastine - Vasomotor rhinitis"
sidebar: mydoc_sidebar
permalink: db09488-mesh-d012223-1.html
toc: false 
---


Path ID: `DB09488_MESH_D012223_1`
{% include image.html url="images/db09488-mesh-d012223-1.png" file="db09488-mesh-d012223-1.png" alt="db09488-mesh-d012223-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C043648 | acrivastine | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| GO:0034776 | response to histamine | BiologicalProcess |
| MESH:D013373 | Substance P | ChemicalSubstance |
| MESH:D020078 | Neurogenic Inflammation | Disease |
| MESH:D012223 | Vasomotor rhinitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Acrivastine | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Histamine H1 Receptor | PARTICIPATES IN | Response To Histamine |
| Response To Histamine | INCREASES ABUNDANCE OF | Substance P |
| Substance P | PARTICIPATES IN | Neurogenic Inflammation |
| Neurogenic Inflammation | CONTRIBUTES TO | Vasomotor Rhinitis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB09488#mechanism-of-action](https://go.drugbank.com/drugs/DB09488#mechanism-of-action){:target="_blank"}